Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Adenovirus provides many opportunities as a vector for delivery of cytotoxic genes to tumours. Polymer coating of adenovirus is known to increase its plasma circulation kinetics, affording the possibility of active and passive targeting to tumours. Here we show that polymer-coating adenovirus (pc-virus) abrogates its normal infectivity in vitro and also in liver following intravenous injection. The coated virus accumulates within solid subcutaneous AB22 mesothelioma tumours 40-times more than unmodified virus, and mediates higher levels of transgene expression within tumours. This is the first demonstration of passive tumour targeting of polymer-coated adenoviruses administered by intravenous injection, and also the first time pc-virus has been shown to be infectious following passive targeting to tumours in vivo. This technology provides an interesting option for delivery of therapeutic viruses to disseminated tumour masses by intravenous injection.

Original publication

DOI

10.1080/10611860701501014

Type

Journal article

Journal

J Drug Target

Publication Date

08/2007

Volume

15

Pages

546 - 551

Keywords

Adenoviridae, Animals, Female, Gene Expression, Gene Targeting, Gene Transfer Techniques, Genetic Therapy, Genetic Vectors, Injections, Intravenous, Mesothelioma, Mice, Mice, Inbred BALB C, Neoplasms, Oncolytic Virotherapy, Permeability, Polymers, Transgenes